Hamburg, 14 January 2021 Toadlet peptide transforms into a deadly weapon against bacteria Researchers at the Technion – Israel Institute of Technology and EMBL Hamburg have discovered remarkable molecular properties of an antimicrobial peptide from the skin of the Australian toadlet. The discovery could inspire the development of novel synthetic drugs to combat bacterial infections
Hamburg, 16 October 2020 Welcome: Meytal Landau Amyloids are protein aggregates known for their role in neurodegenerative diseases like Alzheimer’s or Parkinson’s. They’re also secreted by some bacteria. During a one-year sabbatical at EMBL Hamburg, Israeli structural biologist Meytal Landau made use of the site's infrastructure to deepen her study of amyloids in bacteria and in human diseases. She has now joined EMBL as an associate group leader.